Newsletter Archive
-
01.20.21 -- FDA FY2020 Drug Inspection Observations And Trends
1/20/2021
01/20/21 BioProcess Online Newsletter
-
01.19.21 -- Overcoming Cell And Gene Commercialization Challenges
1/19/2021
01/19/21 BioProcess Online Newsletter
-
01.18.21 -- Slow-Walking The Isolator: A Cautionary Tale
1/18/2021
01/18/21 BioProcess Online Newsletter
-
01.15.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale
1/15/2021
01/15/21 BioProcess Online Newsletter
-
01.14.21 -- Tips For Delivering Biologics Therapies To Market Faster
1/14/2021
01/14/21 BioProcess Online Newsletter
-
01.13.21 -- How To Create A Connected mAb Perfusion Process
1/13/2021
01/13/21 BioProcess Online Newsletter
-
01.13.21 -- Managing Quality, cGMP Compliance Capability Of CMOs
1/13/2021
01/13/21 BioProcess Online Newsletter
-
01.12.21 -- Considerations For CDMO Selection For Large Molecule Drug Development
1/12/2021
01/12/21 BioProcess Online Newsletter
-
01.12.21 -- Advances In COVID-19 Vaccine Development | Emergence Of An mRNA Vaccine Platform
1/12/2021
01/12/21 BioProcess Online Newsletter
-
01.11.21 -- The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
1/11/2021
01/11/21 BioProcess Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more